AsclepiX Therapeutics

AsclepiX Therapeutics Represents the Next Generation of Biologics and Drug Development Technology. AsclepiX Therapeutics designs short biomimetic anti-angiogenic (anti-vascular) and anti-lymphangiogenic peptides using bioinformatics and systems biology approaches. They also leverage the latest advancements in biomaterials and drug delivery to engineer durable, biodegradable nano- and microparticles for systemic delivery of these biomimetic therapeutic peptides. AsclepiX Therapeutics utilizes its platform technology to explore indications in ophthalmology, oncology, and other diseases dependent on angiogenesis and lymphangiogenesis.